Keyphrases
Continuous Glucose Monitoring
100%
Patients with Diabetes
74%
Type 1 Diabetes Mellitus (T1DM)
48%
Hemoglobin A1c (HbA1c)
44%
Incident Cardiovascular Disease
41%
Diabetes
41%
Elderly People
40%
Glucose Sensor
37%
Netherlands
33%
Sensor Technology
33%
Cholesterol Levels
33%
Lipoproteins
33%
LDL Cholesterol
33%
Insulin Resistance
33%
Atherosclerotic Cardiovascular Disease (ASCVD)
33%
Fasting Plasma Glucose
33%
Social Determinants
33%
Triglycerides
33%
Socioeconomic Factors
33%
Subclinical Atherosclerosis
33%
Cardiovascular Risk
33%
Narrative Review
33%
High-risk Population
33%
Type 2 Diabetes Mellitus (T2DM)
25%
Homeostasis Model Assessment of Insulin Resistance (HOMA-IR)
20%
Glycemic Control
19%
Health Outcomes
16%
Low Socioeconomic Status
16%
Ethnic Minorities
16%
Socioeconomic Status
16%
Carotid Intima-media Thickness (cIMT)
12%
Monitoring Technology
10%
Device Usage
8%
Health Systems
8%
Income Status
8%
Healthcare Professionals
8%
Financial Support
8%
Non-clinical Factors
8%
Reimbursement Criteria
8%
Educational Support
8%
Administrative Support
8%
Group Experiences
8%
Living with Diabetes
8%
Insurance Status
8%
Equitable Access
8%
Social Context
8%
Disease Outcome
8%
Healthcare Ecosystem
8%
Patient Engagement
8%
Cardiovascular Disease
6%
Medicine and Dentistry
Diabetes
83%
Cardiovascular Disease
66%
Diabetes Mellitus
66%
Hemoglobin A1c
60%
Triacylglycerol
33%
Cardiovascular Risk
33%
Insulin Resistance
33%
Lipoprotein
33%
Socioeconomic Status
33%
Atherosclerosis
33%
Population Risk
33%
High Density Lipoprotein Cholesterol
33%
Social Determinants of Health
33%
Case-Control Study
33%
Type 2 Diabetes
27%
Glycemic Control
24%
Homeostatic Model Assessment
20%
Maturity Onset Diabetes of the Young
20%
Health Outcomes
16%
Disease
12%
Observational Study
11%
Quality of Life
11%
Age Groups
11%
Health Care
11%
High Risk Population
11%
Glycemic
8%
Ethnic Minority Group
8%
Mediator
8%
Insulin Pump
6%
Elderly Population
6%
Insulin Pen
6%
Outpatient
6%
Cardiovascular System
5%
